Orion Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Orion Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,450	Closed	-$631K	–	539
2023 Q3	$631K	Sell	5,450 -1,800	-25%	-$193K	0.41%	50
2023 Q2	$746K	Hold	7,250	–	–	0.49%	48
2023 Q1	$791K	Hold	7,250	–	–	0.53%	42
2022 Q4	$825K	Sell	7,250 -950	-12%	-$78.9K	0.6%	40
2022 Q3	$507K	Sell	8,200 -55	-0.7%	-$3.84K	0.41%	50
2022 Q2	$658K	Sell	8,255 -1,000	-11%	-$94.7K	0.51%	43
2022 Q1	$974K	Buy	9,255 +200	+2%	+$19.5K	0.59%	41
2021 Q4	$976K	Hold	9,055	–	–	0.55%	45
2021 Q3	$992K	Hold	9,055	–	–	0.6%	47
2021 Q2	$848K	Hold	9,055	–	–	0.53%	48
2021 Q1	$833K	Buy	9,055 +155	+2%	+$13.1K	0.58%	47
2020 Q4	$651K	Buy	+8,900	New	+$662K	0.48%	52

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Orion Capital Management's HZNP Position: Q4 2023 in Review

Orion Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 5,450 shares — an estimated $631K sold.

Orion Capital Management first reported a position in HZNP in Q4 2020 and held it in 12 quarters. The position peaked at $992K in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Orion Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Orion Capital Management sold 5,450 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $631K.
Orion Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 12 quarters.
Orion Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $992K in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Orion Capital Management's 13F filing for Q4 2023, filed 6 Feb 2024.